Ra Medical Systems, Inc.
RMED · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $4 | $6 | $8 |
| - Cash | $3 | $0 | $16 | $15 |
| + Debt | $2 | $0 | $0 | $2 |
| Enterprise Value | $1 | $4 | -$10 | -$5 |
| Revenue | $0 | – | $0 | $0 |
| % Growth | – | – | -36.4% | – |
| Gross Profit | $0 | – | -$0 | -$2 |
| % Margin | 90% | – | -1,050% | -6,990.9% |
| EBITDA | -$11 | – | -$18 | -$29 |
| % Margin | -2,676.9% | – | -129,971.4% | -133,027.3% |
| Net Income | -$22 | – | -$27 | -$27 |
| % Margin | -5,190.7% | – | -191,892.9% | -123,913.6% |
| EPS Diluted | -6.68 | – | -25.98 | -269.91 |
| % Growth | – | – | 90.4% | – |
| Operating Cash Flow | -$9 | -$21 | -$23 | -$28 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$9 | -$21 | -$23 | -$28 |